8th Oct 2007 15:47
Cyprotex PLC08 October 2007 Press Release 8 October 2007 Cyprotex PLC ("Cyprotex" or "the Company") Director share purchases Cyprotex PLC (AIM: CRX), the drug discovery technology and information companywas notified today that David William Evans, a non-executive director of theCompany purchased a total of 25,000 ordinary shares of 0.1p each in the Companyon 4 October 2007 at 3.25p per share. David William Evans now has a totalinterest of 25,000 ordinary shares in the Company, which represents 0.018% ofthe issued share capital of the Company. - Ends - For further information: Cyprotex PLCMark Warburton Tel: +44 (0) 1625 [email protected] www.cyprotex.com Simon Miller Tel: +44 (0) 7930 [email protected] This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L